Frabin Activators
Frabin activators encompass a diverse array of chemical compounds that enhance the protein's functional activity by modulating various cellular pathways and processes related to cytoskeletal dynamics. For instance, the direct interaction of Phosphatidylinositol 4,5-bisphosphate with Frabin promotes its GEF activity on Cdc42, a critical modulator of actin organization, thus enhancing cellular morphogenesis. Similarly, thenon-hydrolyzable GTP analog, GTPγS, sustains Cdc42 in an active state, which then perpetuates Frabin's GEF activity, amplifying the regulatory effects on the actin cytoskeleton. The increase in intracellular calcium via Ionomycin activates CaMKII, which in turn can phosphorylate substrates that influence actin polymerization, where Frabin's GEF function is imperative. Moreover, Jasplakinolide's stabilization of actin filaments complements Frabin's role in actin polymerization, particularly influencing filopodia formation. Lithium chloride indirectly enhances Frabin's activity by stabilizing microtubules, which interact with the actin cytoskeleton, while Calpeptin maintains cytoskeletal integrity, supporting Frabin's involvement in actin dynamics. Forskolin, through increased cAMP levels, activates PKA, which may phosphorylate proteins that interact with Frabin, promoting cytoskeletal remodeling.
Continuing with the theme of cellular signaling modulation, Ara-C induces a DNA damage response that activates Rho GTPases, increasing Frabin's GEF activity as part of the cytoskeletal reorganization response to DNA damage. The use of ML141, which inhibits Cdc42, and NSC23766, which inhibits Rac1, may induce compensatory mechanisms that upregulate Frabin's activity to maintain cytoskeletal dynamics. Lastly, Latrunculin A disrupts actin polymerization, leading to cellular responses that may increase Frabin's role in reestablishing cytoskeletal integrity. These activators, through their respective pathways, collectively enhance the activation of Frabin, ensuring the regulation of the cytoskeletal architecture pivotal for cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
GTPγS is a non-hydrolyzable analog of GTP that can bind to GTPases like Cdc42, maintaining it in an active state. The active Cdc42 can engage Frabin to promote its GEF activity, resulting in the amplification of signaling cascades that regulate cytoskeletal dynamics. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, which can activate calmodulin-dependent kinase II (CaMKII). CaMKII can phosphorylate proteins that modulate actin polymerization where Frabin is involved in the signaling pathways. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and can enhance actin polymerization, a process in which Frabin is actively involved due to its GEF activity, particularly in the formation of filopodia. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3β, which can lead to the stabilization of microtubules. Stabilized microtubules can interact with the actin cytoskeleton where Frabin exerts its effects, hence potentially enhancing its activity. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpeptin is a calpain inhibitor that prevents the cleavage of cytoskeletal proteins, maintaining the integrity of the actin network. This can indirectly sustain Frabin's activity within the actin polymerization processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels and subsequently activating PKA. PKA phosphorylation targets may include proteins modulating actin dynamics, which could synergize with Frabin's role in cytoskeletal remodeling. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a Cdc42 inhibitor. By inhibiting Cdc42, ML141 can induce a compensatory mechanism that upregulates GEFs such as Frabin to restore Cdc42 activity, hence indirectly increasing Frabin's functional activity. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC23766 inhibits Rac1, which may lead to a compensatory increase in Cdc42 activity. Frabin, being a GEF for Cdc42, would have an enhanced role in this scenario as the cell attempts to maintain cytoskeletal dynamics. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A binds to actin monomers, preventing polymerization and leading to the disassembly of actin filaments. The resulting alteration in actin dynamics may enhance Frabin's activity as the cell compensates by activating pathways to reestablish cytoskeletal integrity. | ||||||